<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title>VentureBeat - Latest Comments in Life sciences briefing: Wednesday, Nov. 21, 2007</title><link>http://venturebeat.disqus.com/</link><description>News about Tech, Business and Innovation</description><atom:link href="https://venturebeat.disqus.com/life_sciences_briefing_wednesday_nov_21_2007/latest.rss" rel="self"></atom:link><language>en</language><lastBuildDate>Wed, 21 Nov 2007 20:25:08 -0000</lastBuildDate><item><title>Re: Life sciences briefing: Wednesday, Nov. 21, 2007</title><link>http://venturebeat.com/2007/11/21/life-sciences-briefing-wednesday-nov-21-2007/#comment-14680688</link><description>&lt;p&gt;Mr. Hamilton you should not be so harsh on Reliant.  I have managed a group fantastic human beings into becoming the best in specialty pharmaceuticals.  Give us our due in bringing value to our investors.&lt;/p&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paul Howe</dc:creator><pubDate>Wed, 21 Nov 2007 20:25:08 -0000</pubDate></item><item><title>Re: Life sciences briefing: Wednesday, Nov. 21, 2007</title><link>http://venturebeat.com/2007/11/21/life-sciences-briefing-wednesday-nov-21-2007/#comment-14680687</link><description>&lt;p&gt;This company has been fooling their sales force and the physician market for the last several years.  David P. Hamilton should be applauded for cutting through all the spin and getting right to the truth about this acquisition.  Thank goodness Reliant did not IPO onto some naive investors. I am sure GSK will be hiding this acquisition under "goodwill" for the next several years.&lt;/p&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Albus Dumbledore</dc:creator><pubDate>Wed, 21 Nov 2007 20:22:30 -0000</pubDate></item></channel></rss>